Browse drugs

… Medicines Agency (AIFA) requires semestral HCV testing for all PrEP users, without diversification according to risk factors. Our a…

…urealyticum, and Chlamydia trachomatis Conclusion and Relevance PrEP was highly effective and well tolerated. The high incidence of …

…Introduction Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy, but its impact is lim…

…Introduction HIV pre-exposure prophylaxis (PrEP) is an effective HIV prevention tool, reducing infection risk b…

… and cost-effective; in recent years, pre-exposure prophylaxis (PrEP), a biomedical prevention choice, has gained more recognition. …

…einfections were common, especially among PLWH and HIV-negative PrEP users, with the latter having the shortest interval between inf…

…introduction of PrEP (since 2021) has influenced the demand for nPEP at our centre. To characterise and evaluate both prevention str…

…sciplinary reach-out community-led PrEP programme has increased PrEP access among our cohort of TW. Rates of retention in such a pre…

… HIV acquisition support the need for broader, less restrictive PrEP access, aligned with recent updates to national guidance. To ev…

…In the UK, HIV pre-exposure prophylaxis (PrEP) is largely delivered within sexual health services, which also…

…ramework. Quantitative data will assess changes in knowledge of PrEP and PEP, satisfaction with the intervention and report new diag…

…sactional sex (aPR 2.51; 95% CI 1.15 to 5.48). The rate of oral PrEP use was 19.3% (n=58, 95% CI 15.0% to 24.0%), with 43.0% reporti…